NKMAX Co., Ltd. — Investor Relations & Filings
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 소송등의판결ㆍ결정 (주주총회소집허가) | 2024-11-01 | Korean | |
| 소송등의판결ㆍ결정 (직무집행정지가처분 기각) | 2024-10-25 | Korean | |
| [기재정정]회생절차개시결정 | 2024-10-21 | Korean | |
| [기재정정]회생절차개시결정 | 2024-09-20 | Korean | |
| 최대주주변경 | 2024-09-06 | Korean | |
| 투자판단관련주요경영사항 (이사회결의효력정지가처분 신청 각하) | 2024-09-05 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8021713 | 소송등의판결ㆍ결정 (주주총회소집허가) | 2024-11-01 | Korean | ||
| 8045164 | 소송등의판결ㆍ결정 (직무집행정지가처분 기각) | 2024-10-25 | Korean | ||
| 8046619 | [기재정정]회생절차개시결정 | 2024-10-21 | Korean | ||
| 8076100 | [기재정정]회생절차개시결정 | 2024-09-20 | Korean | ||
| 8079609 | 최대주주변경 | 2024-09-06 | Korean | ||
| 8079931 | 투자판단관련주요경영사항 (이사회결의효력정지가처분 신청 각하) | 2024-09-05 | Korean | ||
| 8093296 | 반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함) | 2024-08-14 | Korean | ||
| 8090084 | 반기보고서 (2024.06) | 2024-08-14 | Korean | ||
| 8114843 | 기타시장안내 (업종변경 안내) | 2024-06-28 | Korean | ||
| 8127564 | 불성실공시법인지정 (공시번복) | 2024-06-12 | Korean | ||
| 8128680 | 회생절차개시결정 | 2024-06-10 | Korean | ||
| 8128676 | 주권매매거래정지기간변경 (회생절차 개시결정) | 2024-06-10 | Korean | ||
| 8132931 | 소송등의제기ㆍ신청(경영권분쟁소송) (주주총회소집허가) | 2024-05-29 | Korean | ||
| 8135435 | 불성실공시법인지정예고 (공시번복) | 2024-05-17 | Korean | ||
| 8136434 | 분기보고서 (2024.03) | 2024-05-16 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NKMAX Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17727/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17727 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17727 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17727 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17727}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NKMAX Co., Ltd. (id: 17727)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.